Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 May;79(9):3011–3014. doi: 10.1073/pnas.79.9.3011

Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen.

E Mizusawa, H L Dahlman, S J Bennett, D M Goldenberg, M F Hawthorne
PMCID: PMC346338  PMID: 6953444

Abstract

Two samples of 2-phenyl-1,2-dicarba-closo-[1-3H]dodecaborane(12) were prepared by treating 1-lithio-2-phenyl-1,2-dicarba-closo-dodecaborane(12) with 3H2O (0.1 and 5.0 Ci/ml, respectively). These tritiated phenylcarborane samples were subsequently converted to corresponding samples of p-[1,2-dicarba-closo-[1-3H]dodecaboran(12)-2-yl]benzenediazonium ion ([3H]DBD) suitable for azo-coupling reactions. Reaction of the two tritiated diazonium ion samples with 2-napthol resulted in the formation of an azo dye (epsilon = 1.98 X 10(4) M-1 cm-1 at 485 nm). Experiments relating absorbance to 3H activity proved the two [3H]DBD sources to have 3.81 X 10(11) and 2.45 X 10(13) cpm of 3H per mol of tritiated carborane substituent. Purified antibodies to carcinoembryonic antigen were coupled to the [3H]DBD and, after extensive dialysis, the average number of carborane moieties per antibody molecule was determined by measuring the 3H activity associated with a known protein concentration. Further examination of these tritiated carborane-labeled antibodies by affinity chromatography proved that boron labeling did not destroy their immunoreactivity. Correlations of azo-coupling conditions (reactant ratios, pH) with immunoreactivity and antibody protein recovery are presented.

Full text

PDF
3011

Images in this article

3014Image
on p.3014

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brownell G. L., Murray B. W., Sweet W. H., Wellum G. R., Soloway A. H. Proceedings: A reassessment of neutron capture therapy in the treatment of cerebral gliomas. Proc Natl Cancer Conf. 1972;7:827–837. [PubMed] [Google Scholar]
  2. CONGER A. D., GILES N. H., Jr The cytogenetic effect of slow neutrons. Genetics. 1950 Jul;35(4):397–419. doi: 10.1093/genetics/35.4.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FARR L. E., SWEET W. H., LOCKSLEY H. B., ROBERTSON J. S. Neutron capture therapy of gliomas using boron. Trans Am Neurol Assoc. 1954;13(79TH):110–113. [PubMed] [Google Scholar]
  4. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GREENFIELD M. A. Energy deposition in tissue by neutrons of various energies and the B10 (n, alpha) Li reaction. Am J Roentgenol Radium Ther Nucl Med. 1956 Aug;76(2):372–375. [PubMed] [Google Scholar]
  6. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  7. Goldenberg D. M., Kim E. E., DeLand F. H., Bennett S., Primus F. J. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res. 1980 Aug;40(8 Pt 2):2984–2992. [PubMed] [Google Scholar]
  8. Goldenberg D. M., Kim E. E., DeLand F. H., van Nagell J. R., Jr, Javadpour N. Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. Science. 1980 Jun 13;208(4449):1284–1286. doi: 10.1126/science.7375942. [DOI] [PubMed] [Google Scholar]
  9. Goldenberg D. M., Kim E. E., Deland F., Spremulli E., Nelson M. O., Gockerman J. P., Primus F. J., Corgan R. L., Alpert E. Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer. 1980 May 15;45(10):2500–2505. doi: 10.1002/1097-0142(19800515)45:10<2500::aid-cncr2820451006>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  10. Hawthorne M. F., Berry T. E., Wegner P. A. The electronic properties of the 1,2- and 1,7-dicarbaclovododecaborane(12) groups bonded at carbon. J Am Chem Soc. 1965 Nov 5;87(21):4746–4750. doi: 10.1021/ja00949a014. [DOI] [PubMed] [Google Scholar]
  11. Hawthorne M. F., Wiersema R. J., Takasugi M. Preparation of tumor-specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets. J Med Chem. 1972 May;15(5):449–452. doi: 10.1021/jm00275a001. [DOI] [PubMed] [Google Scholar]
  12. Kruger P. G. Some Biological Effects of Nuclear Disintegration Products on Neoplastic Tissue. Proc Natl Acad Sci U S A. 1940 Mar 15;26(3):181–192. doi: 10.1073/pnas.26.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mallinger A. G., Jozwiak E. L., Jr, Carter J. C. Preparation of boron-containing bovine -globulin as a model compound for a new approach to slow neutron therapy of tumors. Cancer Res. 1972 Sep;32(9):1947–1950. [PubMed] [Google Scholar]
  14. SWEET W. H. The uses of nuclear disintegration in the diagnosis and treatment of brain tumor. N Engl J Med. 1951 Dec 6;245(23):875–878. doi: 10.1056/NEJM195112062452301. [DOI] [PubMed] [Google Scholar]
  15. Trachtenberg M. C., Kornblith P. L., Häuptli J. Biophysical properties of cultured human glial cells. Brain Res. 1972 Mar 24;38(2):279–298. doi: 10.1016/0006-8993(72)90713-5. [DOI] [PubMed] [Google Scholar]
  16. Zahl P. A., Cooper F. S., Dunning J. R. Some in vivo Effects of Localized Nuclear Disintegration Products on a Transplantable Mouse Sarcoma. Proc Natl Acad Sci U S A. 1940 Oct 15;26(10):589–598. doi: 10.1073/pnas.26.10.589. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES